UBS Wealth Management (WM) makes strides in impact investing through its recent collaboration to push development for cancer cures. The Swiss private bank announced that it will work with MPM Capital, a bioventure investment firm, to help with academic research and better access to cancer care in the developing world. The drive spotlights impact investing – a nascent but increasingly…
Have a confidential tip? Get in touch [email protected]